Table 3.

The association between level of hepatoma‐derived growth factor and the types of therapy

	Logistic regression adjusted for age and sex				Unadjusted rank‐sum test
	Coefficient	95% confidence interval		p Value	p Value (rank‐sum)
PDE5	0.046	−0.078	0.17	0.471	0.156
ERA	−0.038	−0.149	0.073	0.502	0.456
PCA	0.148	0.036	0.26	0.009	0.004
CCB	−0.034	−0.218	0.151	0.721	0.826
cGMP	0.027	−0.441	0.496	0.909	0.78

Note: Bold values denote statistical significance at the p < 0.05 level.

Abbreviations: CCB, calcium channel blockers; cGMP, cyclic guanosine monophosphate; ERA, endothelin receptor antagonist; PCA, prostacyclin analogs; PDE5, phosphodiesterase‐5 inhibitor.